When does Creon’s patent end in the UK?
The specific UK patent (or set of patents) that governs Creon’s protection is not provided in the information available here, so an exact “patent expiry date” for Creon in the UK can’t be stated from the provided material.
What can be checked to find Creon’s UK expiry date?
To determine when Creon comes off patent in the UK, you typically need to look up the relevant UK patents and any related patent extensions for the specific Creon product strength/formulation (because different patents can cover different aspects, such as the active ingredient, formulation, or additional manufacturing/process claims).
Common places to verify this include:
- UK Intellectual Property Office (UKIPO) patent records
- The Medicines and Healthcare products Regulatory Agency (MHRA) and listings connected to medicines regulatory exclusivity
- The UK “Supplementary Protection Certificate” (SPC) status, if one applies to the relevant patent
Could exclusivity end later than the patent?
Even if a core patent expires, drug supply may still be protected by other mechanisms (for example, linked patents or SPC-related protection). UK market access timing for competitors often depends on the full set of protections in place, not just one patent.
If you tell me the exact Creon product, I can narrow it down
If you share:
- the exact product name/strength (e.g., Creon 10,000, Creon 25,000), and
- whether you mean “patent expiry” or “when generics/biosimilar equivalents can launch,”
I can help you map which protections are usually checked for that product and how to find the date using the relevant public records.
Sources
No sources were provided with the prompt, so no citations are available.